4U93
Crystal Structure of Hsp90-alpha N-domain Bound to the Inhibitor NVP-HSP990
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SSRL BEAMLINE BL9-2 |
Synchrotron site | SSRL |
Beamline | BL9-2 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2006-06-08 |
Detector | ADSC QUANTUM 210r |
Wavelength(s) | 1.0 |
Spacegroup name | I 2 2 2 |
Unit cell lengths | 66.726, 99.237, 91.561 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 67.270 - 1.550 |
R-factor | 0.1861 |
Rwork | 0.185 |
R-free | 0.21320 |
Structure solution method | MOLECULAR REPLACEMENT |
Data reduction software | DENZO |
Data scaling software | SCALEPACK |
Phasing software | MOLREP |
Refinement software | REFMAC (5.2.0019) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 67.270 | 1.630 |
High resolution limit [Å] | 1.550 | 1.550 |
Rmerge | 0.081 | 0.187 |
Number of reflections | 41892 | |
<I/σ(I)> | 22.1 | 7.2 |
Completeness [%] | 94.5 | 70.5 |
Redundancy | 6.9 | 4.7 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 6.5 | 298 | Protein is used at 10mg/ml. Crystallant is: 10-20% (w/v) PEG2K MME, 50-200 mM magnesium chloride, 100 mM sodium cacodylate Equal ratio of protein to crystallant use for drops |